Consumer Staples: The Sector Institutions Keep Skipping

Every quarter of 13F filings produces a list of sectors the smart money crowded into. Consumer staples has not been on that list for three years running, and the Q2 2026 filings didn't change it.

That's unusual, because on paper the sector looks like exactly what a cautious institutional allocator should want right now: predictable cash flows, dividends, and multiples that have compressed while everything AI-adjacent has expanded. The S&P 500 Consumer Staples index gained about 10.7% year to date through late August, versus roughly 11.9% for the S&P 500 excluding staples. That's not a collapse — it's a slow, grinding lag that has now stretched long enough for the valuation gap to become genuinely large.

Why the sector got left behind

Two separate stories are being priced at once, and they compound.

The first is opportunity cost. Capital that could sit in a beverage company compounding at mid-single digits has spent three years sitting in semiconductors and hyperscalers instead. The relative performance gap between staples and technology over that stretch runs to something like 70 percentage points. No portfolio manager gets paid for owning the flat line next to that.

The second is a structural fear specific to food and beverage: GLP-1 weight-loss drugs. The bear case is straightforward — if a meaningful share of the population eats and drinks less, the volume base under packaged food, snacks, and soda permanently shrinks. That thesis has been in the market since 2023, and it has done real damage to multiples regardless of whether the underlying volume decline ever materialized at the forecast scale. Recent commentary suggests GLP-1 adoption growth is decelerating, which would soften the headwind, but sentiment hasn't caught up to that yet.

The result is a sector trading at a discount to its own history while the index around it trades at a premium to its own history. PepsiCo's P/E, for instance, fell from roughly 24 to 18 across 2026, against an S&P 500 multiple near 30.

What the 13F data actually shows

Here's the useful part, and the part most sector commentary skips: cheapness alone tells you nothing about whether institutions are moving. Positioning does.

If you pull staples exposure across the tracked investor list, the pattern in Q2 2026 is not "everyone quietly accumulating." It's a small number of long-horizon, valuation-driven managers holding legacy positions they've held for years, and almost nobody initiating. That's a very different signal from the energy or utilities rotations of recent quarters, where you could see genuine new-position formation across multiple unrelated funds in the same window.

This distinction matters. A sector can be underowned because the smart money hasn't gotten there yet, or underowned because the smart money looked and passed. The 13F data can't tell you which — but it can tell you whether anyone has started, and right now the honest answer for staples is: barely.

The overlap tool is the fastest way to sanity-check this yourself. Run any two large value-oriented managers against each other and count how many staples names appear in the shared set. Then run two AI-exposed growth funds. The asymmetry is stark, and it's been stark for a while.

The setup worth watching

The contrarian case doesn't require staples to become exciting. It requires two things: the GLP-1 volume fear to prove smaller than priced, and the AI-driven growth premium to stop widening. Neither is a prediction. Both are observable.

And this is where 13F filings earn their keep. Institutional rotation into a hated sector doesn't announce itself in price first — it shows up as new positions in filings while the chart still looks bad. That was true of energy in 2020 and financials earlier this year. If staples turn, the first evidence will likely be a cluster of unrelated managers initiating in the same quarter, visible 45 days after the fact.

The macro consensus view is a useful cross-check here too. If aggregate positioning is shifting defensive while staples exposure stays near zero, that's a genuine inconsistency — and inconsistencies in institutional positioning are usually where the next rotation starts.

For now, the data says what it says. Staples are cheap, they're defensive, and the smart money still isn't buying. The interesting moment is the quarter that stops being true.

---

Data sourced from public SEC 13F filings. Educational research only — not investment advice.